1. Home
  2. HTCR vs MBRX Comparison

HTCR vs MBRX Comparison

Compare HTCR & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

HOLD

Current Price

$0.23

Market Cap

6.5M

Sector

Technology

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$2.05

Market Cap

6.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTCR
MBRX
Founded
2009
2015
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.1M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
HTCR
MBRX
Price
$0.23
$2.05
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$105.50
AVG Volume (30 Days)
385.6K
229.4K
Earning Date
03-30-2026
03-19-2026
Dividend Yield
56.77%
N/A
EPS Growth
66.67
N/A
EPS
N/A
N/A
Revenue
$30,407,229.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.19
N/A
52 Week Low
$0.22
$0.25
52 Week High
$1.66
$7.98

Technical Indicators

Market Signals
Indicator
HTCR
MBRX
Relative Strength Index (RSI) 36.78 33.10
Support Level $0.22 $0.37
Resistance Level $0.30 $5.22
Average True Range (ATR) 0.02 0.15
MACD -0.00 0.05
Stochastic Oscillator 11.50 42.62

Price Performance

Historical Comparison
HTCR
MBRX

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Share on Social Networks: